FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernard Têtu

Research Profile

Chemicals & Drugs

Procedures

Immunohistochemistry

Disorders

Concepts & Ideas

Anatomy

Stromal Cells

Physiology

Gene Expression Regulation, Neoplastic

Co-author Network

Publications

TOP 3
Dominique Trudel; Dimcho Bachvarov; Pierre Douville; Jean Grégoire; Marie Plante; Marie-Claude Renaud; Bernard Têtu; Isabelle Bairati
Human epididymis protein 4 (HE4) and ovarian cancer prognosis.
Fadi Brimo; Simone Chevalier; Louis Lacombe; Fred Saad; Eleanora Scarlata; Kanishka Sircar; Bernard Têtu; Armen Aprikian
Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical prostatectomy.
Bernard Têtu; Marie-Claude Trudel; Jean Boulanger; Jean-Paul Fortin; Marie-Pierre Gagnon; Christine Houde; Guy Paré; Geneviève Roch; Claude Sicotte
[The Eastern Quebec telepathology network: a real collective project].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernard Têtu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Dominique Trudel; Dimcho Bachvarov; Pierre Douville; Jean Grégoire; Marie Plante; Marie-Claude Renaud; Bernard Têtu; Isabelle Bairati
Human epididymis protein 4 (HE4) and ovarian cancer prognosis.
Gynecologic oncology 2012;127(3):511-5.
2012: Fadi Brimo; Simone Chevalier; Louis Lacombe; Fred Saad; Eleanora Scarlata; Kanishka Sircar; Bernard Têtu; Armen Aprikian
Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical prostatectomy.
Cell and tissue banking 2012;13(4):631-8.
2012: Bernard Têtu; Marie-Claude Trudel; Jean Boulanger; Jean-Paul Fortin; Marie-Pierre Gagnon; Christine Houde; Guy Paré; Geneviève Roch; Claude Sicotte
[The Eastern Quebec telepathology network: a real collective project].
Médecine sciences : M/S 2012;28(11):993-9.
2012: Dominique Trudel; Isabelle Bairati; Laurent Bazinet; Vincent Fradet; David P Labbé; Bernard Têtu
Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies.
Gynecologic oncology 2012;126(3):491-8.
2012: Sophie Pâquet; Paul S Rennie; Bernard Têtu; Mélanie Verreault; Alain Bélanger; Ladan Fazli; Laurent Grosse; Olivier Barbier
Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.
The Journal of clinical endocrinology and metabolism 2012;97(3):E428-32.
2012: Alice Nourissat; Bernard Têtu; Abdenour Nabid; Isabelle Bairati; François Brochet; André Fortin; Michel Gélinas; François Meyer
Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(3):591-9.
2012: Marie-Claude Trudel; Bernard Têtu; Guy Paré; Claude Sicotte
The effects of a regional telepathology project: a study protocol.
BMC health services research 2012;12():64.
2011: Pierre-Luc Mercier; Marie Plante; Marie-Claude Renaud; Bernard Têtu; Magdalena Bachvarova; Isabelle Bairati; Karim Ghani; Jean Gregoire; Dimcho Bachvarov
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
Molecular oncology 2011;5(5):438-53.
2011: Michel Roy; Bernard Têtu; Geneviève Bouchard-Fortier; Jean Grégoire; Ion Popa; Marie-Claude Renaud; Marie Plante
Value of sentinel node mapping in cancer of the cervix.
Gynecologic oncology 2011;122(2):269-74.
2011: Judith Bellemare; Mélanie Rouleau; Mario Harvey; Ion Popa; Georges Pelletier; Bernard Têtu; Chantal Guillemette
Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans.
The Journal of pathology 2011;223(3):425-35.
2011: Étienne Audet-Walsh; Johanie Lépine; Jean Grégoire; Marie Plante; Patrick Caron; Bernard Têtu; Pierre Ayotte; Jacques Brisson; Lyne Villeneuve; Alain Bélanger; Chantal Guillemette
Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics.
The Journal of clinical endocrinology and metabolism 2011;96(2):E330-9.
2010: Dominique Trudel; Yves Fradet; François Meyer; Bernard Têtu
Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis.
Human pathology 2010;41(12):1694-701.
2010: Bernard Têtu; Jean Boulanger; Christine Houde
[Telepathology project on virtual slides of eastern Quebec: a clinical project carried out in 21 areas].
Annales de pathologie 2010;30(5 Suppl 1):25-7.
2010: Jean-François Haince; Michel Houde; Guillaume Beaudry; Sylvain L'Esperance; Geneviève Garon; Marie Desaulniers; Laurie J Hafer; James I Heald; Stephen Lyle; Steven R Grossman; Bernard Têtu; Daniel J Sargent; Yves Fradet
Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes.
Journal of clinical pathology 2010;63(6):530-7.
2010: Johanie Lépine; Étienne Audet-Walsh; Jean Grégoire; Bernard Têtu; Marie Plante; Vincent Menard; Pierre Ayotte; Jacques Brisson; Patrick Caron; Lyne Villeneuve; Alain Bélanger; Chantal Guillemette
Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways.
The Journal of clinical endocrinology and metabolism 2010;95(6):2689-98.
2010: Alice Nourissat; Isabelle Bairati; Elodie Samson; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu; François Meyer
Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer.
Cancer 2010;116(9):2275-83.
2010: Gaëlle Gendronneau; Margot Lemieux; Mélanie Morneau; Josée Paradis; Bernard Têtu; Nancy Frenette; Josée Aubin; Lucie Jeannotte
Influence of Hoxa5 on p53 tumorigenic outcome in mice.
The American journal of pathology 2010;176(2):995-1005.
2009: Jefferson Terry; Emina Emilia Torlakovic; John Garratt; Denise Miller; Martin Köbel; Jesse Cooper; Shakir Bahzad; Dragana Pilavdzic; Frances O'Malley; Anne E O'Brien; Sandip SenGupta; Edward Alport; Bernard Têtu; Bryan Knight; Norman M Pettigrew; Richard Berendt; Robert Wolber; Martin J Trotter; Robert H Riddell; Louis Gaboury; Ford Elms; anthony magliocco; Penny Barnes; Allen M Gown; C Blake Gilks
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2009;17(5):375-82.
2009: Jacinthe Chênevert; Bernard Têtu; Marie Plante; Michel Roy; Marie-Claude Renaud; Jean Grégoire; Katherine Grondin; Valérie Dubé
Indication and method of frozen section in vaginal radical trachelectomy.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2009;28(5):480-8.
2009: François Meyer; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu; Isabelle Bairati
Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2970-6.
2009: Bernard Têtu
Diagnosis of urothelial carcinoma from urine.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22 Suppl 2():S53-9.
2009: Cherifa Ayari; Hélène LaRue; Hélène Hovington; Marc Decobert; François Harel; Alain Bergeron; Bernard Têtu; Louis Lacombe; Yves Fradet
Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
European urology 2009;55(6):1386-95.
2009: Jacinthe Chênevert; Paul Bessette; Marie Plante; Bernard Têtu; Valérie Dubé
Mixed ovarian large cell neuroendocrine carcinoma, mucinous adenocarcinoma, and teratoma: a report of two cases and review of the literature.
Pathology, research and practice 2009;205(9):657-61.
2008: Jonathan Beaudoin; Martine Périgny; Bernard Têtu; Marcel Lebel
A patient with a juxtaglomerular cell tumor with histological vascular invasion.
Nature clinical practice. Nephrology 2008;4(8):458-62.
2008: Bernard Têtu; Ion Popa; Isabelle Bairati; Sylvain L'Esperance; Magdalena Bachvarova; Marie Plante; François Harel; Dimcho Bachvarov
Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(8):1002-10.
2008: Dominique Trudel; Yves Fradet; François Meyer; François Harel; Bernard Têtu
Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.
Human pathology 2008;39(5):731-9.
2008: Bernard Têtu
Morphological changes induced by androgen blockade in normal prostate and prostatic carcinoma.
Best practice & research. Clinical endocrinology & metabolism 2008;22(2):271-83.
2008: François Meyer; Isabelle Bairati; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu
Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients.
International journal of cancer. Journal international du cancer 2008;122(7):1679-83.
2008: Martine Périgny; Isabelle Bairati; Isabelle Harvey; Michel Beauchemin; François Harel; Marie Plante; Bernard Têtu
Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer.
American journal of clinical pathology 2008;129(2):226-31.
2008: Melanie K Sackett; Isabelle Bairati; François Meyer; Edith Jobin; Sébastien Lussier; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu
Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):67-73.
2007: Ion Popa; Yves Fradet; Geneviève Beaudry; Hélène Hovington; Guillaume Beaudry; Bernard Têtu
Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(11):1121-7.
2007: François Meyer; Isabelle Bairati; Edith Jobin; Michel Gélinas; André Fortin; Abdenour Nabid; Bernard Têtu
Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients.
Nutrition and cancer 2007;59(1):29-35.
2006: Isabelle Bairati; François Meyer; Edith Jobin; Michel Gélinas; André Fortin; Abdenour Nabid; François Brochet; Bernard Têtu
Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients.
International journal of cancer. Journal international du cancer 2006;119(9):2221-4.
2006: Ion Popa; Marie Plante; Marie-Claude Renaud; Michel Roy; Bernard Têtu
Negative sentinel lymph node accurately predicts negative status of pelvic lymph nodes in uterine cervix carcinoma.
Gynecologic oncology 2006;103(2):649-53.
2006: François Meyer; Bernard Têtu; Isabelle Bairati; Louis Lacombe; Yves Fradet
Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer.
The Canadian journal of urology 2006;13(5):3255-60.
2006: Dimcho Bachvarov; Sylvain L'Esperance; Ion Popa; Magdalena Bachvarova; Marie Plante; Bernard Têtu
Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy.
International journal of oncology 2006;29(4):919-33.
2006: Bernard Têtu; Dominique Trudel; Chang Shu Wang
[Proteases by reactive stromal cells in cancer: an attractive therapeutic target].
Bulletin du cancer 2006;93(9):944-8.
2006: Sylvain L'Esperance; Ion Popa; Magdalena Bachvarova; Marie Plante; Nancy Patten; Lin Wu; Bernard Têtu; Dimcho Bachvarov
Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.
International journal of oncology 2006;29(1):5-24.
2006: Jean-François Gagnon; Olivier Bernard; Lyne Villeneuve; Bernard Têtu; Chantal Guillemette
Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1850-8.
2006: Bernard Têtu; Jacques Brisson; Chang Shu Wang; Hélène Lapointe; Geneviève Beaudry; Caty Blanchette; Dominique Trudel
The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis.
Breast cancer research : BCR 2006;8(3):R28.
2006: Jean Thibaudeau; Johanie Lépine; Jelena Tojcic; Yannick Duguay; Georges Pelletier; Marie Plante; Jacques Brisson; Bernard Têtu; Simon Jacob; Louis Perusse; Alain Bélanger; Chantal Guillemette
Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.
Cancer research 2006;66(1):125-33.
2005: Sylvain Trahan; Bernard Têtu; Paul-Emile Raymond
Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
Human pathology 2005;36(12):1316-21.
2005: Bernard Têtu; François Gagné
History of gynecological pathology. XVIII: Dr. Louis Berger.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2005;24(4):385-90.
2005: Isabelle Bairati; François Meyer; Michel Gélinas; André Fortin; Abdenour Nabid; François Brochet; Jean-Philippe Mercier; Bernard Têtu; François Harel; Belkacem Abdous; Eric Vigneault; Sylvie Vass; Pierre del Vecchio; Jean Roy
Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5805-13.
2005: Isabelle Bairati; François Meyer; Michel Gélinas; André Fortin; Abdenour Nabid; François Brochet; Jean-Philippe Mercier; Bernard Têtu; François Harel; Benoît Mâsse; Eric Vigneault; Sylvie Vass; Pierre del Vecchio; Jean Roy
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Journal of the National Cancer Institute 2005;97(7):481-8.
2005: Valérie Dubé; Michel Roy; Marie Plante; Marie-Claude Renaud; Bernard Têtu
Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2005;24(2):138-46.
2005: J Riopel; Marie Plante; Marie-Claude Renaud; Michel Roy; Bernard Têtu
Lymph node metastases in low-grade endometrial stromal sarcoma.
Gynecologic oncology 2005;96(2):402-6.
2005: Bernard Têtu; Rabi Tiguert; François Harel; Yves Fradet
ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(1):83-9.
2004: Johanie Lépine; Olivier Bernard; Marie Plante; Bernard Têtu; Georges Pelletier; Fernand Labrie; Alain Bélanger; Chantal Guillemette
Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.
The Journal of clinical endocrinology and metabolism 2004;89(10):5222-32.
2004: Isabelle Harvey; Bernard Têtu
[Amyloidosis of the seminal vesicles: a local condition with no systemic impact].
Annales de pathologie 2004;24(3):236-40; quiz 227.
2004: Pouya Pakneshan; Bernard Têtu; Shafaat A Rabbani
Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3035-41.
2004: Caroline Tanguay; Marie Plante; Marie-Claude Renaud; Michel Roy; Bernard Têtu
Vaginal radical trachelectomy in the treatment of cervical cancer: the role of frozen section.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(2):170-5.
2004: Valérie Dubé; Chantal Veilleux; Marie Plante; Bernard Têtu
Primary villoglandular adenocarcinoma of cloacogenic origin of the vulva.
Human pathology 2004;35(3):377-9.
2004: Yannick Duguay; Monica McGrath; Johanie Lépine; Jean-François Gagné; Susan E Hankinson; GRaham Colditz; David J Hunter; Marie Plante; Bernard Têtu; Alain Bélanger; Chantal Guillemette; Immaculata DeVivo
The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk.
Cancer research 2004;64(3):1202-7.
2003: Dominique Trudel; Yves Fradet; François Meyer; François Harel; Bernard Têtu
Significance of MMP-2 expression in prostate cancer: an immunohistochemical study.
Cancer research 2003;63(23):8511-5.
2003: Marie Plante; Marie-Claude Renaud; Bernard Têtu; François Harel; Michel Roy
Laparoscopic sentinel node mapping in early-stage cervical cancer.
Gynecologic oncology 2003;91(3):494-503.
2003: C Tanguay; I Harvey; M Houde; J R Srigley; Bernard Têtu
Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: report of two cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(5):512-4.
2002: Chang Shu Wang; Bernard Têtu
Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction.
International journal of cancer. Journal international du cancer 2002;99(6):792-9.
2002: Joel Rousseau; Bernard Têtu; Danielle Caron; Patrick Malenfant; Paola Cattaruzzi; Marie Audette; Charles Doillon; Jacques P Tremblay; Benoit Guérette
RCAS1 is associated with ductal breast cancer progression.
Biochemical and biophysical research communications 2002;293(5):1544-9.
2002: Christian Couture; Hélène Raybaud-Diogène; Bernard Têtu; Isabelle Bairati; Danielle Murry; Josée Allard; André Fortin
p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
Cancer 2002;94(3):713-22.
2001: Bernard Têtu; Jacques Brisson; Chang Shu Wang; Hélène Lapointe; Geneviève Beaudry; Caty Blanchette
Expression of cathepsin D, stromelysin-3, and urokinase by reactive stromal cells on breast carcinoma prognosis.
Cancer 2001;92(11):2957-64.
2001: F Meyer; Isabelle Bairati; C Bédard; Louis Lacombe; Bernard Têtu; Yves Fradet
Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancer.
Urology 2001;58(2 Suppl 1):71-7.
2001: S Labonté; Bernard Têtu; D Boucher; Hélène LaRue
Transitional cell carcinoma of the endometrium associated with a benign ovarian Brenner tumor: a case report.
Human pathology 2001;32(2):230-2.
2000: Hélène LaRue; P Allard; Maryse Simoneau; C Normand; C Pfister; Lynne Moore; François Meyer; Bernard Têtu; Yves Fradet
P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.
Carcinogenesis 2000;21(1):101-6.
1999: C Pfister; Lynne Moore; P Allard; Hélène LaRue; Louis Lacombe; Bernard Têtu; François Meyer; Yves Fradet
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4079-84.
1999: F Meyer; L Moore; Isabelle Bairati; Louis Lacombe; Bernard Têtu; Yves Fradet
Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific antigen failure.
The Journal of urology 1999;162(6):2024-8.
1999: C Pfister; Louis Lacombe; M C Vezina; Lynne Moore; Hélène LaRue; Bernard Têtu; François Meyer; Yves Fradet
Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors.
Human pathology 1999;30(11):1350-5.
1999: Bernard Têtu; Jacques Brisson; Hélène Lapointe; Chang Shu Wang; P Bernard; Caty Blanchette
Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases.
Breast cancer research and treatment 1999;55(2):137-47.
1998: Bernard Têtu; Jacques Brisson; V Plante; P Bernard
p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(9):823-30.
1998: Bernard Têtu; Jacques Brisson; Hélène Lapointe; P Bernard
Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer.
Human pathology 1998;29(9):979-85.
1997: C S Wang; Hélène LaRue; A Fortin; G Gariépy; Bernard Têtu
mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy.
Breast cancer research and treatment 1997;45(1):63-74.
1997: Hélène Raybaud-Diogène; André Fortin; R Morency; J Roy; RA Monteil; Bernard Têtu
Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1030-8.
1996: Bernard Têtu; P Allard; Y Fradet; N Roberge; P Bernard
Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancer.
Human pathology 1996;27(9):922-6.
1995: Bernard Têtu; Jacques Brisson; J Landry; Jacques Huot
Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: an immunohistochemical study.
Breast cancer research and treatment 1995;36(1):93-7.
1994: Bernard Têtu; Jacques Brisson
Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy.
Cancer 1994;73(9):2359-65.
1993: Bernard Têtu; L Vaillancourt; J P Camilleri; P Bruneval; L Bernier; R Tourigny
Juxtaglomerular cell tumor of the kidney: report of two cases with a papillary pattern.
Human pathology 1993;24(11):1168-74.
1993: Bernard Têtu; Jacques Brisson; C Côté; S Brisson; D Potvin; N Roberge
Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study.
International journal of cancer. Journal international du cancer 1993;55(3):429-35.
1989: Y Gagnon; Bernard Têtu
Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases.
Cancer 1989;64(4):892-8.